Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Holly Pharmaceutical Co., Ltd. is a pharmaceutical manufacturer based in Zibo, Shandong, China, specializing in the production of Active Pharmaceutical Ingredients (APIs) and finished dosage forms. The company focuses on therapeutic areas such as endocrinology, cardiovascular health, and anti-infectives. Its product portfolio includes widely used medications like Gliclazide, Metformin, and various antibiotics. Shandong Holly operates GMP-certified facilities and provides contract manufacturing services to global partners. The company is recognized for its expertise in small molecule synthesis and large-scale chemical production. It serves both the domestic Chinese market and international clients through its export-oriented manufacturing capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Holly Pharmaceutical.